BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Uto NS, Amitani H, Atobe Y, Sameshima Y, Sakaki M, Rokot N, Ataka K, Amitani M, Inui A. Herbal Medicine Ninjin'yoeito in the Treatment of Sarcopenia and Frailty. Front Nutr 2018;5:126. [PMID: 30619872 DOI: 10.3389/fnut.2018.00126] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 4.4] [Reference Citation Analysis]
Number Citing Articles
1 Ishigami T, Ito H, Nakada Y, Uneda K. Kampo medicine in modern cardiology. Traditional & Kampo Medicine 2022. [DOI: 10.1002/tkm2.1347] [Reference Citation Analysis]
2 Bagherniya M, Mahdavi A, Shokri-Mashhadi N, Banach M, Von Haehling S, Johnston TP, Sahebkar A. The beneficial therapeutic effects of plant-derived natural products for the treatment of sarcopenia. J Cachexia Sarcopenia Muscle 2022;13:2772-90. [PMID: 35961944 DOI: 10.1002/jcsm.13057] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
3 Amitani H, Chiba S, Amitani M, Michihara S, Takemoto R, Han L, Fujita N, Takahashi R, Inui A. Impact of Ninjin’yoeito on frailty and short life in klotho-hypomorphic (kl/kl) mice. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.973897] [Reference Citation Analysis]
4 Shimoyama T, Kaneda M, Yoshida S, Michihara S, Fujita N, Han L, Takahashi R. Ninjin’yoeito ameliorated PPE-induced pulmonary emphysema and anxiety/depressive-like behavior in aged C57BL/6J mice. Front Pharmacol 2022;13:970697. [DOI: 10.3389/fphar.2022.970697] [Reference Citation Analysis]
5 Otsuka S, Fukumaru K, Tani A, Takada S, Kikuchi K, Norimatsu K, Matsuzaki R, Matsuoka T, Sakakima H, Omiya Y, Mizuno K, Matsubara Y, Maruyama I. Analysis of the Effects of Ninjin’yoeito on Physical Frailty in Mice. IJMS 2022;23:11183. [DOI: 10.3390/ijms231911183] [Reference Citation Analysis]
6 Kubota K, Watanabe T, Katsurabayashi S, Iwasaki K. Ninjinyoeito reduces β‐amyloid 25–35 ‐induced axon damage via nerve growth factor. Traditional & Kampo Medicine 2022;9:89-97. [DOI: 10.1002/tkm2.1320] [Reference Citation Analysis]
7 Motoo Y, Shinozaki K, Takagi T, Ito S, Fujita H, Munemoto Y, Yoshida N, Baba E, Shindo Y, Nishiuchi T, Miura M, Morita S, Tsuji A. Randomized controlled trial of the significance of combined use with Ninjin’yoeito in CapeOX + Bmab therapy for patients with unresectable advanced/recurrent colorectal cancer. Medicine: Case Reports and Study Protocols 2022;3:e0196. [DOI: 10.1097/md9.0000000000000196] [Reference Citation Analysis]
8 Tsutsumi S, Watanabe T, Hatae A, Hirata M, Omori H, Taniguchi C, Nagao M, Kubota K, Katsurabayashi S, Iwasaki K. Ninjinyoeito exerts an antidepressant‐like effect by enhancing the central noradrenergic system. Traditional & Kampo Medicine 2022;9:25-31. [DOI: 10.1002/tkm2.1306] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Ou Y, Jobu K, Ishida T, Morisawa S, Fujita H, Kawada K, Yoshioka S, Miyamura M. Saikokeishikankyoto extract alleviates muscle atrophy in KKAy mice. J Nat Med 2022. [PMID: 34997408 DOI: 10.1007/s11418-021-01590-2] [Reference Citation Analysis]
10 Yaku H, Kaneda K, Kitamura J, Kato T, Kimura T. Kampo medicine for the holistic approach to older adults with heart failure. J Cardiol 2021:S0914-5087(21)00366-X. [PMID: 34974939 DOI: 10.1016/j.jjcc.2021.12.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Uto N, Amitani M, Amitani H, Kurazono S, Kobayashi Y, Sakaki M, Suzuki H, Inui A, Owaki T, Asakawa A. Survey of problems in Kampo curriculum and the need for interdisciplinary collaboration education in Japanese medical, pharmacy, dental, and nursing departments. Neuropeptides 2021;92:102225. [PMID: 35030376 DOI: 10.1016/j.npep.2021.102225] [Reference Citation Analysis]
12 Aomatsu N, Shigemitsu K, Nakagawa H, Morooka T, Ishikawa J, Yamashita T, Tsuruoka A, Fuke A, Motoyama K, Kitagawa D, Ikeda K, Maeda K, Shirano M, Rinka H. Efficacy of Ninjin'yoeito in treating severe coronavirus disease 2019 in patients in an intensive care unit. Neuropeptides 2021;90:102201. [PMID: 34753072 DOI: 10.1016/j.npep.2021.102201] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Kiyomi A, Matsuda A, Nara M, Yamazaki K, Imai S, Sugiura M. Immunological Differences in Human Peripheral Blood Mononuclear Cells Treated with Traditional Japanese Herbal Medicines Hochuekkito, Juzentaihoto, and Ninjin'yoeito from Different Pharmaceutical Companies. Evid Based Complement Alternat Med 2021;2021:7605057. [PMID: 34589133 DOI: 10.1155/2021/7605057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Ohsawa M, Makino T, Takimoto Y, Inui A. Application of Kampo medicines for the palliation of cancer cachexia. Neuropeptides 2021;90:102188. [PMID: 34488048 DOI: 10.1016/j.npep.2021.102188] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Wang L, Han W, Iwasaki Y, Yermek R, Sharp GWG, Seino Y, Yada T. Onion component, isoalliin, stimulates feeding and activates the arcuate nucleus neuropeptide Y, ghrelin- and Ninjin'yoeito-responsive neurons. Neuropeptides 2021;89:102180. [PMID: 34293597 DOI: 10.1016/j.npep.2021.102180] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Matsumoto T, Takiyama M, Sakamoto T, Kaifuchi N, Watanabe J, Takahashi Y, Setou M. Pharmacokinetic study of Ninjin'yoeito: Absorption and brain distribution of Ninjin'yoeito ingredients in mice. J Ethnopharmacol 2021;279:114332. [PMID: 34129897 DOI: 10.1016/j.jep.2021.114332] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
17 Zang L, Shimada Y, Nakayama H, Katsuzaki H, Kim Y, Chu DC, Juneja LR, Kuroyanagi J, Nishimura N. Preventive Effects of Green Tea Extract against Obesity Development in Zebrafish. Molecules 2021;26:2627. [PMID: 33946279 DOI: 10.3390/molecules26092627] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
18 Zhang L, Gopalasingam G, Herzog H. Ninjin'yoeito, a herbal medicine, enhances glucose tolerance in mice. Neuropeptides 2021;88:102150. [PMID: 33895618 DOI: 10.1016/j.npep.2021.102150] [Reference Citation Analysis]
19 Zhang L, Clark T, Gopalasingam G, Neely GG, Herzog H. Ninjin'yoeito modulates feeding and activity under negative energy balance conditions via the NPY system. Neuropeptides 2021;87:102149. [PMID: 33882337 DOI: 10.1016/j.npep.2021.102149] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
20 Kashima M. Case Report: Ninjin'yoeito May Improve Quality of Life After Hospitalization for Acute Illness in Patients With Frailty. Front Nutr 2021;8:547512. [PMID: 33937301 DOI: 10.3389/fnut.2021.547512] [Reference Citation Analysis]
21 Jeon C, Kim S, Son C. Recovery of an Elderly Kwashiorkor Patient by Korean Medicine: A Case Report. J Korean Med 2021;42:129-135. [DOI: 10.13048/jkm.21010] [Reference Citation Analysis]
22 Kwon CY, Lee B, Ha DJ. Herbal medicine for behavioral and psychological symptoms of dementia: A protocol for systematic review. Medicine (Baltimore) 2021;100:e24577. [PMID: 33663066 DOI: 10.1097/MD.0000000000024577] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Miyamoto A, Asai K, Kadotani H, Maruyama N, Kubo H, Okamoto A, Sato K, Yamada K, Ijiri N, Watanabe T, Kawaguchi T. Ninjin'yoeito Ameliorates Skeletal Muscle Complications in COPD Model Mice by Upregulating Peroxisome Proliferator-Activated Receptor γ Coactivator-1α Expression. Int J Chron Obstruct Pulmon Dis 2020;15:3063-77. [PMID: 33273811 DOI: 10.2147/COPD.S280401] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
24 Hirai K, Homma T, Matsunaga T, Akimoto K, Yamamoto S, Suganuma H, Kashima A, Sato H, Ebato T, Miyata Y, Ohta S, Inoue H, Kusumoto S, Suzuki S, Tanaka A, Sagara H. Usefulness of Ninjin'yoeito for Chronic Obstructive Pulmonary Disease Patients with Frailty. The Journal of Alternative and Complementary Medicine 2020;26:750-7. [DOI: 10.1089/acm.2020.0083] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
25 Takayama S, Tomita N, Arita R, Ono R, Kikuchi A, Ishii T. Kampo Medicine for Various Aging-Related Symptoms: A Review of Geriatric Syndrome. Front Nutr 2020;7:86. [PMID: 32766269 DOI: 10.3389/fnut.2020.00086] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
26 Akimoto K, Yamaguchi T, Naraoka Y, Hu A, Kobayashi H. Depigmentory Effects of Keishibukuryogankayokuinin in Human Epidermal Melanocytes. Health 2019;11:869-879. [DOI: 10.4236/health.2019.117070] [Reference Citation Analysis]